SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VALGIMIGLI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.317
AS - Asia 1.892
EU - Europa 768
SA - Sud America 335
AF - Africa 41
OC - Oceania 2
Totale 6.355
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.249
SG - Singapore 750
CN - Cina 474
BR - Brasile 253
VN - Vietnam 242
DE - Germania 152
HK - Hong Kong 150
UA - Ucraina 134
GB - Regno Unito 110
TR - Turchia 68
FI - Finlandia 67
IT - Italia 65
FR - Francia 52
RU - Federazione Russa 52
SE - Svezia 44
IN - India 43
JP - Giappone 43
MX - Messico 31
BD - Bangladesh 26
AR - Argentina 25
CA - Canada 25
ID - Indonesia 23
PL - Polonia 23
ZA - Sudafrica 20
CO - Colombia 15
EC - Ecuador 14
IQ - Iraq 14
BE - Belgio 11
ES - Italia 11
PK - Pakistan 11
VE - Venezuela 11
IE - Irlanda 9
NL - Olanda 9
AL - Albania 7
SA - Arabia Saudita 6
CR - Costa Rica 5
LT - Lituania 5
MA - Marocco 5
MY - Malesia 5
UY - Uruguay 5
UZ - Uzbekistan 5
CL - Cile 4
CZ - Repubblica Ceca 4
KE - Kenya 4
KZ - Kazakistan 4
PY - Paraguay 4
AT - Austria 3
EG - Egitto 3
JO - Giordania 3
OM - Oman 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IL - Israele 2
JM - Giamaica 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
SN - Senegal 2
TN - Tunisia 2
AU - Australia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 6.355
Salva come PNG Salva come JPEG
Città #
Singapore 433
Ashburn 413
Woodbridge 290
Fairfield 286
Beijing 175
Santa Clara 174
San Jose 168
Ann Arbor 164
Chandler 153
Hong Kong 147
Houston 139
Jacksonville 133
Seattle 118
Wilmington 107
Ho Chi Minh City 82
New York 79
Cambridge 65
Los Angeles 59
Hanoi 50
Dallas 44
Princeton 43
Tokyo 42
Izmir 38
Helsinki 37
Nanjing 37
Lauterbourg 31
San Diego 29
Bremen 25
Buffalo 25
São Paulo 25
Munich 24
Council Bluffs 23
Mexico City 22
Shanghai 22
Boardman 21
Warsaw 20
Milan 19
Jakarta 17
Orem 17
Falkenstein 16
Chicago 14
Shenyang 14
Jiaxing 13
Phoenix 13
Redwood City 13
Brooklyn 12
Denver 12
London 12
Tianjin 12
Brussels 11
Dearborn 11
Nanchang 11
Bologna 10
Changsha 10
Johannesburg 10
Montreal 10
Baghdad 9
Da Nang 9
Frankfurt am Main 9
Jinan 9
Moscow 9
Rio de Janeiro 9
Boston 8
Haiphong 8
Hefei 8
Ninh Bình 8
San Francisco 8
Stockholm 8
Toronto 8
Washington 8
Atlanta 7
Chennai 7
Dublin 7
Ferrara 7
Leawood 7
Nuremberg 7
San Mateo 7
Auburn Hills 6
Charlotte 6
Curitiba 6
Dhaka 6
Manchester 6
Norwalk 6
Poplar 6
Shenzhen 6
Amsterdam 5
Ankara 5
Dong Ket 5
Falls Church 5
Hangzhou 5
Mountain View 5
San José 5
The Dalles 5
Thái Nguyên 5
Zhengzhou 5
Addison 4
Augusta 4
Belo Horizonte 4
Bengaluru 4
Biên Hòa 4
Totale 4.285
Salva come PNG Salva come JPEG
Nome #
Poor response to clopidogrel: current and future options for its management 271
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 258
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 239
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 237
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 236
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) 228
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction 211
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress 200
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 196
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 192
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 181
Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy 180
Cohort profile The ESC-EORP Chronic Ischemic Cardiovascular Disease Long-Term (CICD LT) registry 178
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial 174
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 172
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study 171
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 170
Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial 165
Value of Platelet Reactivity in Predicting Response to Treatment and Clinical Outcome in Patients Undergoing Primary Coronary Intervention. Insights Into the STRATEGY Study 164
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates 160
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial 159
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 157
Poor responsiveness to clopidogrel. Drug-specific or class-effect? 154
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study 153
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial 148
Pharmacogenomic Polygenic Response Score Predicts Ischemic Events and Cardiovascular Mortality in Clopidogrel-Treated Patients 147
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 145
Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention? Insights From the EXAMINATION Trial 141
CD34+ cells mobilization in myocardial infarction: a link with heart failure? 135
High-dose bolus tirofiban and sirolimus-eluting stent versus abciximab and bare metal stent in acute myocardial infarction (STRATEGY) study 132
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI 126
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale: The FABOLUS FASTER Trial 113
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 110
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 104
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 98
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial 89
Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies—meta-analysis of prospective studies 85
Stable angina pectoris 70
Temporal and genotype-driven variations of factor VII levels in patients with acute myocardial infarction 63
null 61
null 61
Totale 6.434
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.979
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.979
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021151 0 0 0 0 0 0 0 0 0 51 70 30
2021/2022453 16 51 54 20 23 14 35 27 14 33 49 117
2022/2023362 46 5 19 49 68 58 9 29 47 8 16 8
2023/2024275 25 26 11 8 17 81 10 13 5 8 5 66
2024/2025951 10 26 87 28 126 120 20 19 181 100 133 101
2025/20262.561 284 148 253 336 373 183 220 179 294 291 0 0
Totale 6.434